This Article  • Full text  • PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Citing articles on Web of Science (18)  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Topic Collections  • Medical Practice  • Medical Ethics  • Neonatology and Infant Care  • Endocrine Diseases  • Diabetes Mellitus  • Genetics  • Genetic Counseling/ Testing/ Therapy  • Alert me on articles by topic  Social Bookmarking   What's this?

The Ethics of Predictive Diabetes Mellitus Screening Research in Newborns

Lainie Friedman Ross, MD, PhD

Arch Pediatr Adolesc Med. 2003;157:89-95.

Type 1 diabetes mellitus is the most common metabolic disease of childhood. Two states offer newborn screening to identify children with a genetic predisposition to it. It is a voluntary test offered in conjunction with the mandatory newborn metabolic screening. There are no preventive treatments, but children discovered to be at increased risk may participate in follow-up studies to determine whether and when the child develops autoantibodies (preclinical disease) or overt diabetes. This study examined the ethics of predictive genetic research in newborns for type 1 diabetes. Prediction research has serious psychosocial implications, and research designs must account for them. The study concluded that, to minimize harm to infants and their families, (1) if the research does not incorporate a prevention strategy, studies should avoid disclosure of results; and (2) if disclosure is necessary, then the research should be restricted to newborns with an affected first-degree relative.

From the Department of Pediatrics and MacLean Center for Clinical Medical Ethics, The University of Chicago, Chicago, Ill.

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Diabetic Subjects Diagnosed Through the Diabetes Prevention Trial-Type 1 (DPT-1) Are Often Asymptomatic With Normal A1C at Diabetes Onset
Triolo et al.
Diabetes Care 2009;32:769-773.
ABSTRACT | FULL TEXT  

Information and consent for newborn screening: practices and attitudes of service providers
Kerruish et al.
J. Med. Ethics 2008;34:648-652.
ABSTRACT | FULL TEXT  

Maternal Psychological Reaction to Newborn Genetic Screening for Type 1 Diabetes
Kerruish et al.
Pediatrics 2007;120:e324-e335.
ABSTRACT | FULL TEXT  

Against Newborn Screening for Type 1 Diabetes
Ross
Arch Pediatr Adolesc Med 2007;161:616-617.
FULL TEXT  

Newborn Screening: Complexities in Universal Genetic Testing
Green et al.
AJPH 2006;96:1955-1959.
ABSTRACT | FULL TEXT  

Practice Notes: Strategies in Health Education
Health Educ Behav 2005;32:577-582.
 

Pediatricians' Attitudes Toward Expanding Newborn Screening
Acharya et al.
Pediatrics 2005;116:e476-e484.
ABSTRACT | FULL TEXT  

Depressive Symptoms in Mothers of Infants Identified as Genetically at Risk for Type 1 Diabetes
Hood et al.
Diabetes Care 2005;28:1898-1903.
ABSTRACT | FULL TEXT  

Maternal Efforts to Prevent Type 1 Diabetes in At-Risk Children
Baughcum et al.
Diabetes Care 2005;28:916-921.
ABSTRACT | FULL TEXT  

Vitamin D in Type 1 Diabetes Prevention
Harris
J. Nutr. 2005;135:323-325.
ABSTRACT | FULL TEXT  

Clinical Characteristics of Children Diagnosed With Type 1 Diabetes Through Intensive Screening and Follow-Up
Barker et al.
Diabetes Care 2004;27:1399-1404.
ABSTRACT | FULL TEXT  

Maternal Anxiety Associated With Newborn Genetic Screening for Type 1 Diabetes
Bennett Johnson et al.
Diabetes Care 2004;27:392-397.
ABSTRACT | FULL TEXT  

Need for Genetic Education for Type 1 Diabetes--Reply
Ross
Arch Pediatr Adolesc Med 2003;157:936-936.
FULL TEXT  

Need for Genetic Education for Type 1 Diabetes
Dorman et al.
Arch Pediatr Adolesc Med 2003;157:935-936.
FULL TEXT